Phone: (212) 746-5788
Fax: (212) 746-0975
March 24, 2010 1:15 am
In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide ... - UroToday
Google News - Prostate Cancer
In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide ... UroToday A human prostate cancer (PC3) xenograft model was established which reflects acquired in vivo resistance towards metronomic cyclophosphamide (CPA) treatment ... |
|